Why Alzheimer’s Is a Failure of Paradigm
For decades, the dominant approach to brain disease has followed a familiar script:
identify a disease → find a micro-level mechanism → design a drug to block it.
And yet, despite billions spent on research and drug development, rates of Alzheimer’s and cognitive decline continue to rise.
What if the problem isn’t that we haven’t found the right drug but that we’re operating from the wrong paradigm?
That’s the core question explored in this recent episode of the Evolution of Medicine, where James Maskell sits down with Ari Whitten to unpack an evolutionary perspective on Alzheimer’s and brain disease.
The Foundational Insight: Paradigm Shapes Solutions
Ari opens the conversation with a deceptively simple idea:
The way we conceptualize a problem dictates how we attempt to solve it.
Modern medicine largely views disease as a collection of isolated failures at the cellular or biochemical level. This framing worked extraordinarily well for infectious diseases in the mid-20th century antibiotics like penicillin could eliminate a single identifiable cause.
But chronic diseases are different.
Cancer, heart disease, and dementia don’t have a single root cause. They emerge from systems under long-term stress and trying to solve them with the same “one target, one drug” model has proven largely ineffective.
From an evolutionary standpoint, this isn’t a failure of effort.
It’s a failure of paradigm.
Alzheimer’s as a Disease of Evolutionary Mismatch
One of the most compelling parts of the conversation looks not at diseased populations but at healthy ones.
Humans lived as hunter-gatherers for over 95% of our evolutionary history. And populations that still live this way today show something extraordinary:
Near-zero rates of Alzheimer’s and dementia
Exceptionally low cardiovascular disease
Preserved cognitive function into advanced age
The most striking example is the Tsimane tribe in Bolivia which is arguably the healthiest aging population ever studied.
Despite no access to modern medicine:
Dementia rates are under 1%
Individuals routinely live into their 80s and 90s
Cognitive decline is rare, not expected
This isn’t genetics.
It’s environment, lifestyle, and daily challenge.
The implication is profound: Alzheimer’s may not be an inevitable disease of aging. It may be a disease of mismatch between our biology and modern life.
What’s Missing from the Conversation: Physiological Resilience
Ari introduces a concept that bridges evolutionary biology and clinical practice: physiological resilience.
Rather than asking, “What’s broken?”, the better question becomes:
“How much reserve capacity does this system have?”
Key forms of reserve capacity related to brain health include:
Cognitive reserve
Cardiovascular reserve
Muscular reserve
Mitochondrial reserve
The body is adaptive. Systems that are regularly challenged grow stronger. Systems that are underused atrophy.
This principle applies to:
Neural circuitry
Energy production
Blood flow
Stress tolerance
And the data is staggering.
Women with high cardiovascular fitness in midlife show an 88% reduction in dementia risk later in life.
Older adults who maintain lifelong physical activity preserve mitochondrial function comparable to young adults.
Education and cognitive challenge dramatically reduce Alzheimer’s risk, even in those with high-risk genes like APOE4.
The message is clear: resilience is built, not prescribed.
From Paradigm to Practice: Where TruNeura Comes In
Understanding the evolutionary paradigm is powerful, but insight alone doesn’t change outcomes.
The real challenge is execution.
That’s where TruNeura comes in.
TruNeura is designed specifically to help practitioners operationalize this evolutionary, resilience-based approach to brain health at scale.
TruNeura enables clinicians to:
Assess cognitive, metabolic, inflammatory, and resilience-related drivers of decline
Track multi-system inputs over time, not just symptoms
Deliver structured lifestyle, movement, cognitive, and metabolic interventions
Build cognitive, cardiovascular, and mitochondrial reserve intentionally
Support patients through longitudinal behavior change, not one-off protocols
Collaborate with other practitioners on complex brain cases
In other words, TruNeura is the platform that turns evolutionary theory into clinical reality.
Not by chasing single mechanisms, but by rebuilding the conditions under which healthy brains naturally emerge.
The Future of Brain Health Is Not a Pill
This conversation with Ari Whitten points to a future where brain health is no longer about suppressing decline but about cultivating resilience.
Alzheimer’s is not destiny.
Cognitive decline is not inevitable.
And the tools to reverse course already exist, if we’re willing to change the lens.
Watch the full conversation above, and if you’re a clinician looking to execute this paradigm in your practice, TruNeura was built for exactly this moment.
The future of brain health isn’t a drug.
It’s a system.
